Brief: Organon To Pay Sun Pharmaceutical $120 Mln Termination Fee If Deal Terminated
April 27 (Reuters) - Organon & Co OGN.N: ORGANON & CO - IF DEAL TERMINATED UNDER CERTAIN CIRCUMSTANCES, CO TO PAY SUN PHARMACEUTICAL HOLDINGS USA TERMINATION FEE OF $120 MILLION - SEC FILING Source text: [ID:n0001193125-26-178718] Further company coverage: OGN.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sun Pharmaceutical Industries
See all newsROI-US blue wave reshapes Asia's winners and losers: Manishi Raychaudhuri
Brief: Sun Pharma Clarifies Regarding News Report Relating To Company's Assam Facility
Street View: India's Sun Pharma Organon buy, psoriasis drug are risk factors
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses